タウタンパク質
関連文献

Goedert M, Crowther RA, Garner CC (May 1991). “Molecular characterization of microtubule-associated proteins tau and MAP2”. Trends in Neurosciences 14 (5):  193–9. doi:10.1016/0166-2236(91)90105-4. PMID 1713721.
Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Watanabe A, Titani K, Ihara Y (1995). “Hyperphosphorylation of tau in PHF”. Neurobiology of Aging 16 (3):  365–71; discussion 371–80. doi:10.1016/0197-4580(95)00027-C. PMID 7566346.
Heutink P (April 2000). “Untangling tau-related dementia”. Human Molecular Genetics 9 (6):  979–86. doi:10.1093/hmg/9.6.979. PMID 10767321.
Goedert M, Spillantini MG (July 2000). “Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease”. Biochimica et Biophysica Acta 1502 (1):  110–21. doi:10.1016/S0925-4439(00)00037-5. PMID 10899436.
Morishima-Kawashima M, Ihara Y (November 2001). “[Recent advances in Alzheimer's disease]”. Seikagaku. The Journal of Japanese Biochemical Society 73 (11):  1297–307. PMID 11831025.
Blennow K, Vanmechelen E, Hampel H (2002). “CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease”. Molecular Neurobiology 24 (1–3):  87–97. doi:10.1385/MN:24:1-3:087. PMID 11831556.
Ingram EM, Spillantini MG (December 2002). “Tau gene mutations: dissecting the pathogenesis of FTDP-17”. Trends in Molecular Medicine 8 (12):  555–62. doi:10.1016/S1471-4914(02)02440-1. PMID 12470988.
Pickering-Brown S (2004). “The tau gene locus and frontotemporal dementia”. Dementia and Geriatric Cognitive Disorders 17 (4):  258–60. doi:10.1159/000077149. PMID 15178931.
van Swieten JC, Rosso SM, van Herpen E, Kamphorst W, Ravid R, Heutink P (2004). “Phenotypic variation in frontotemporal dementia and parkinsonism linked to chromosome 17”. Dementia and Geriatric Cognitive Disorders 17 (4):  261–4. doi:10.1159/000077150. PMID 15178932.
Kowalska A, Jamrozik Z, Kwieciński H (2004). “Progressive supranuclear palsy--parkinsonian disorder with tau pathology”. Folia Neuropathologica 42 (2):  119–23. PMID 15266787.
Rademakers R, Cruts M, van Broeckhoven C (October 2004). “The role of tau (MAPT) in frontotemporal dementia and related tauopathies”. Human Mutation 24 (4):  277–95. doi:10.1002/humu.20086. PMID 15365985.
Lee HG, Perry G, Moreira PI, Garrett MR, Liu Q, Zhu X, Takeda A, Nunomura A, Smith MA (April 2005). “Tau phosphorylation in Alzheimer's disease: pathogen or protector?”. Trends in Molecular Medicine 11 (4):  164–9. doi:10.1016/j.molmed.2005.02.008. PMID 15823754.
Hardy J, Pittman A, Myers A, Gwinn-Hardy K, Fung HC, de Silva R, Hutton M, Duckworth J (August 2005). “Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens”. Biochemical Society Transactions 33 (Pt 4):  582–5. doi:10.1042/BST0330582. PMID 16042549.
Deutsch SI, Rosse RB, Lakshman RM (December 2006). “Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications”. Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 (8):  1369–80. doi:10.1016/j.pnpbp.2006.04.007. PMID 16793187.
Williams DR (October 2006). “Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau”. Internal Medicine Journal 36 (10):  652–60. doi:10.1111/j.1445-5994.2006.01153.x. PMID 16958643.
Pittman AM, Fung HC, de Silva R (October 2006). “Untangling the tau gene association with neurodegenerative disorders”. Human Molecular Genetics. 15 15 Spec No 2 (Review Issue 2):  R188–95. doi:10.1093/hmg/ddl190. PMID 16987883.
Roder HM, Hutton ML (April 2007). “Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease”. Expert Opinion on Therapeutic Targets 11 (4):  435–42. doi:10.1517/14728222.11.4.435. PMID 17373874.
van Swieten J, Spillantini MG (January 2007). “Hereditary frontotemporal dementia caused by Tau gene mutations”. Brain Pathology 17 (1):  63–73. doi:10.1111/j.1750-3639.2007.00052.x. PMID 17493040.
Caffrey TM, Wade-Martins R (July 2007). “Functional MAPT haplotypes: bridging the gap between genotype and neuropathology”. Neurobiology of Disease 27 (1):  1–10. doi:10.1016/j.nbd.2007.04.006. PMC 2801069. PMID 17555970. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801069/.
Delacourte A (2005). “Tauopathies: recent insights into old diseases”. Folia Neuropathologica 43 (4):  244–57. PMID 16416389.
Hirokawa N, Shiomura Y, Okabe S (October 1988). “Tau proteins: the molecular structure and mode of binding on microtubules”. The Journal of Cell Biology 107 (4):  1449–59. doi:10.1083/jcb.107.4.1449. PMC 2115262. PMID 3139677. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2115262/.